Atlas Trials

Comparison of Relapse Rate After 12 Weeks Verses 20 Weeks Steroid Therapy for the Management of First Episode of Steroid Sensitive Nephrotic Syndrome

Clinical trial NCT04713410 · UNKNOWN

Trial details

NCT number
NCT04713410
Sponsor
Shaheed Zulfiqar Ali Bhutto Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Steroid-Sensitive Nephrotic Syndrome
Start date
2020-12-22
Primary completion
2022-09-04
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.